AstraZeneca agrees to lower drug prices for Medicaid under Trump administration deal

chicagotribune.com/2025/10/10/astrazeneca-medicaid-trump-administration-deal

WASHINGTON — AstraZeneca on Friday became the second major pharmaceutical manufacturer to announce it had agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration that avoided its threats of steep tariffs.
President Donald Trump made…

This story appeared on chicagotribune.com, 2025-10-11 00:32:55.
The Entire Business World on a Single Page. Free to Use →